Sunday, May 22, 2011

Grey matter's role in the ability to process reward


In addition to studying new ways to treat and heal those struggling with cocaine addiction , I focus a great deal of research on the changes that are created in those who abuse the drug.

Of of the key findings of a report that was released in December's Journal of Cognitive Neuroscience, was that there appeared to be dramatically less gray matter in key brain regions associated with decision-making and thought-processing in cocaine abusers based on research performed by the Brookhaven National Laboratory .

Less brain matter would result in compromised ability to experience pleasure and control behaviour. Abusers, are less likely to consider consequences.

This repeats similar earlier studies the Brookhaven group has released on alcoholism and earlier rat studies completed by the European Journal of Neuroscience that showed that drug-experienced animals fail to adapt their behavior to avoid adverse outcomes. These deficits are similar to those caused by damage to the orbitofrontal cortex.

Friday, May 13, 2011

Women and Treatment

Studies have supported the notion that women have greater success in treatment programs designed for women only.  The studies that I have reviewed indicate that mixed-gender treatment does not readily address the barriers that many women face when wanting to access treatment.

The barriers focused on included childcare, prenatal care, parenting, vocational support.  Women in mixed-gender treatment programs expressed difficulties when dealing with trauma in those settings.  Women-only programs also tend to provide extended ancillary services so that they can continue out-patient care.

These programs tend to promote success of clients because of they provide much needed connections to other social services that will promote independence and community support. One study found at a 21-month follow-up that 19% of the clients were considered abstinent, and 26% of patients were employed during their involvement with the program. Additional follow-up studies are necessary to determine long-term success.

Tuesday, May 10, 2011

Will Vaccines help fight addiction?

Current medications to treat addiction focus on drug replacement. Methadone or Suboxone for Heroine users; nicotine patches for smokers. Other medications block activity in the brain's reward system.  Alkermes Inc.'s once-monthly Vivitrol injection does this for alcoholics and opioid addicts, while Pfizer Inc.'s Chantix pills block the brain's pleasure receptors activated when people smoke. 

 Scientists are hard at work and have seen some success looking at vaccines to treat nicotine and cocaine addiction that will work in the bloodstream rather than the brain and work by tricking the body into thinking that the drug molecules are foreign bodies and blocking them from activating the pleasure centres in the brain.

A possible advantages of a vaccine, which would still have to be used alongside conventional psychological therapy and possibly other medications, is that it could require a once-a-month injection, as opposed to current anti-addiction medications that sometimes need to be taken several times a day.

Recent results from a test of an anticocaine vaccine in mice at Weill Cornell Medical College in New York were encouraging. After the injection, mice were feed cocaine laced water with a higher percentage dosage of cocaine that humans would take and showed absolutely no effects from the drug.

Sunday, May 1, 2011

Canada - Methadone Benefits to be cut

With rising numbers of people in MMT programs, the costs are rapidly increasing for the Canadian government to provide access to treatments. In rural areas, this is particularly evident with the number of people relying on government funding to travel to get doses. In 2001, 181 people claimed travelling expenses. This climbed to over 1300 in 2011.

The new limits that the government has put into place cap the expense to only $200 every 18 months.

This will make it extremely difficult to continue programs in areas away from major metropolitan areas.